construction release_alert

Profile editing will be unavailable for Scholars@Duke profiles from June 11-24, 2026
as manual profile data entry transitions to Elements. More information about the transition.

cancel

ALVR106 in Treatment of High-Risk Patients with Respiratory Viral Infections After HSCT

Clinical Trial Grant

Duke Scholars

Principal Investigator Mitchell Eric Horwitz Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Allovir, Inc.

Start Date

May 27, 2021